Stay updated on IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial

Sign up to get notified when there's something new on the IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The date has been updated from January 10, 2025, to March 10, 2025.
    Difference
    0.3%
    Check dated 2025-03-11T04:19:50.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    5%
    Check dated 2025-02-24T20:41:00.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    6%
    Check dated 2025-02-10T09:45:16.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.3%
    Check dated 2025-02-03T07:32:52.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.3%
    Check dated 2025-01-19T22:12:06.000Z thumbnail image
  9. Check
    73 days ago
    Change Detected
    Summary
    The website has added a new version (v2.14.0) of the 'type of intervention' on January 10, 2025, while the previous version (v2.13.3) was removed on September 19, 2024.
    Difference
    2%
    Check dated 2025-01-12T17:44:53.000Z thumbnail image

Stay in the know with updates to IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial page.